Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response

The receptor binding domain (RBD) of the SARS-CoV-2 spike protein is the primary target of neutralizing antibodies and is a component of almost all vaccine candidates. Here, RBD immunogens were created with stabilizing amino acid changes that improve the neutralizing antibody response, as well as ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Dickey, Thayne H., Tang, Wai Kwan, Butler, Brandi, Ouahes, Tarik, Orr-Gonzalez, Sachy, Salinas, Nichole D., Lambert, Lynn E., Tolia, Niraj H.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8132226/
https://ncbi.nlm.nih.gov/pubmed/34013270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.05.09.443238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados